GO:0032720 negative regulation of tumor necrosis factor production: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032720 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor (TNF) production [1,2,5].
• TNF is a master pro-inflammatory cytokine; its production is tightly controlled at transcriptional, post-transcriptional, and secretory levels [5,6].
• Key negative regulators include tristetraprolin (TTP/ZFP36), which destabilizes TNF mRNA via AU-rich elements, and NLRP12, which attenuates TNF-alpha production in macrophages.
• Post-translational modifications such as N-glycosylation can negatively regulate TNF expression in mouse macrophages.
• Dysregulation of this process contributes to chronic inflammatory diseases, sepsis, and autoimmune disorders [3,5,8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of negative regulators of TNF production [6,8].
Description
Tumor necrosis factor (TNF), originally named cachectin, is a pleiotropic pro-inflammatory cytokine produced primarily by activated macrophages and monocytes. Its production must be tightly controlled because excessive or sustained TNF drives tissue damage, chronic inflammation, and autoimmune pathology [3,5]. The Gene Ontology term GO:0032720, negative regulation of tumor necrosis factor production, captures the diverse cellular processes that restrain TNF biosynthesis and secretion [1,2,5]. This term is essential for annotating gene products that act as brakes on inflammation, including RNA-binding proteins, signaling inhibitors, and metabolic regulators [3,4,6]. Research into GO:0032720 spans transcriptional repression, mRNA destabilization, translational inhibition, and blockade of secretion [5,6]. For example, tristetraprolin (TTP) binds AU-rich elements in the TNF 3' untranslated region and promotes mRNA decay, providing a critical feedback inhibition loop in macrophages. NLRP12 acts as a negative regulator of TNF-alpha production in Burkholderia pseudomallei-infected RAW264.7 macrophages. N-glycosylation has also been shown to negatively regulate TNF expression in mouse macrophages. These mechanisms are conserved across species and are central to inflammatory disease research [1,8]. Understanding GO:0032720 is important for immunology, cancer biology, and drug discovery because therapeutic strategies often aim to boost or mimic endogenous negative regulation of TNF [5,8]. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to provide a research-grade overview of the term, its molecular players, and experimental approaches for studying it.
negative regulation of tumor necrosis factor production At A Glance
| GO ID | GO:0032720 |
|---|---|
| GO term | negative regulation of tumor necrosis factor production |
| Ontology | biological_process |
| Definition | Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production. |
| Synonym | inhibition of tumor necrosis factor production; negative regulation of TNF-alpha production; downregulation of tumor necrosis factor production; negative regulation of cachectin production |
| Major function | Restraining TNF biosynthesis and secretion to prevent excessive inflammation |
| Related processes | Negative regulation of cytokine production; regulation of TNF-mediated signaling; inflammatory response |
| Key regulators | Tristetraprolin (ZFP36), NLRP12, N-glycosylation pathway enzymes, CD40 signaling modulators |
| Disease relevance | Sepsis, rheumatoid arthritis, inflammatory bowel disease, cancer-related inflammation |
What Is GO:0032720?
GO:0032720 (negative regulation of tumor necrosis factor production) is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production [1,2,5]. It encompasses negative regulation at the levels of TNF gene transcription, mRNA stability, translation, and secretion [5,6]. Synonyms include inhibition of tumor necrosis factor production, negative regulation of TNF-alpha production, and negative regulation of cachectin production [3,4].
Why Is negative regulation of tumor necrosis factor production Important in Cell Biology?
GO:0032720 is critically important because TNF is a central driver of acute and chronic inflammatory diseases, and its production must be actively suppressed to maintain immune homeostasis [3,5,8]. Loss of negative regulation leads to excessive TNF, which contributes to septic shock, autoimmune disorders, and tissue destruction [5,8]. Conversely, enhancing negative regulation of TNF is a therapeutic goal in inflammatory diseases [3,6]. Understanding the genes and mechanisms annotated to GO:0032720 provides targets for anti-inflammatory drug development and biomarkers for disease susceptibility [4,6].
• Prevents lethal systemic inflammation during infection by limiting TNF burst [3,5].
• Maintains immune tolerance and prevents autoimmune tissue damage [5,8].
• Tristetraprolin-mediated TNF mRNA decay is a paradigm for post-transcriptional control of inflammation.
• NLRP12 acts as a negative regulator of TNF-alpha in macrophages, linking innate immune sensors to inflammation resolution.
• N-glycosylation represents a metabolic checkpoint that negatively regulates TNF expression.
• Dysregulation of TNF negative regulation is implicated in rheumatoid arthritis and inflammatory bowel disease.
• TNF overproduction contributes to cancer-related inflammation and tumor progression.
• Dietary factors such as essential fatty acid balance can modulate TNF production in macrophages.
• Genetic variants affecting TNF regulation influence susceptibility to sepsis and inflammatory diseases.
• CRISPR screens can identify novel negative regulators of TNF production for therapeutic targeting [6,8].
What Happens During negative regulation of tumor necrosis factor production?
Transcriptional repression of TNF gene expression
In simple terms: The cell reduces the reading of the TNF gene into messenger RNA.
Negative regulation of TNF production can occur at the transcriptional level, where signaling pathways and transcription factors suppress TNF gene promoter activity. For example, CD40 ligation in BV-2 microglial cells regulates TNF-alpha expression, and dominant negative Lps(d)/Ran down-regulates endotoxin-induced TNF-alpha production [2,8]. These mechanisms reduce the initial burst of TNF mRNA synthesis in response to inflammatory stimuli [5,8].
Post-transcriptional mRNA destabilization
In simple terms: The messenger RNA for TNF is marked for destruction before it can make protein.
Tristetraprolin (TTP) binds to AU-rich elements in the 3' untranslated region of TNF mRNA and promotes its deadenylation and decay, providing feedback inhibition of macrophage TNF-alpha production. This post-transcriptional mechanism is essential for preventing excessive TNF synthesis and is a key component of GO:0032720.
Translational inhibition and protein modification
In simple terms: Even if mRNA exists, the cell can block its translation into protein or modify the protein to reduce activity.
N-glycosylation negatively regulates TNF expression in mouse macrophages, indicating that post-translational modifications can control TNF protein levels. Additionally, negative regulation of TNF secretion has been described, where intracellular trafficking or processing is inhibited. These layers ensure that TNF production is dampened even when transcription is activated [4,5].
Feedback inhibition by anti-inflammatory signals
In simple terms: Anti-inflammatory molecules tell the cell to stop making TNF.
NLRP12 attenuates TNF-alpha production in Burkholderia pseudomallei-infected RAW264.7 macrophages, demonstrating that innate immune sensors can act as negative regulators. Dietary essential fatty acid balance also regulates TNF production in mouse macrophages, linking nutritional status to GO:0032720. These feedback mechanisms prevent runaway inflammation [3,7].
Regulation by stromal and microenvironmental cues
In simple terms: Other cells in the tissue can send signals that reduce TNF production.
TNF signaling itself can regulate stromal cell-derived factor 1α/CXCL12 in the myocardium, illustrating crosstalk between TNF and tissue microenvironments. Such interactions may indirectly influence negative regulation of TNF production through feedback loops. This highlights the importance of context in GO:0032720.
Key Genes Involved in GO:0032720 negative regulation of tumor necrosis factor production
The following genes and proteins have been experimentally linked to negative regulation of tumor necrosis factor production (GO:0032720) in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ZFP36 (TTP) | Binds AU-rich elements in TNF mRNA and promotes decay | Feedback inhibition of macrophage TNF-alpha production |
| NLRP12 | Attenuates TNF-alpha production in infected macrophages | Negative regulator of inflammation in Burkholderia pseudomallei infection |
| CD40 | Ligation modulates TNF-alpha expression in microglia | Regulation of TNF in BV-2 microglial cells |
| Lps(d)/Ran | Dominant negative down-regulation of endotoxin-induced TNF-alpha | Genetic control of endotoxin response |
| CXCL12 | Regulated by TNF signaling in myocardial stroma | Crosstalk between TNF and chemokine networks |
| N-glycosylation pathway enzymes | Negatively regulate TNF expression in macrophages | Post-translational control of TNF |
| Dietary fatty acid regulators | Essential fatty acid balance modulates TNF production | Nutritional immunology |
| Monocyte/macrophage transcription factors | Regulate TNF-alpha production and gene expression | Transcriptional control in monocytes |
| TNF receptor signaling components | Feedback regulation of TNF production | Autocrine/paracrine loops |
| MAPK phosphatases | Dephosphorylate signaling intermediates to dampen TNF | Innate immune signaling brakes |
| SOCS proteins | Suppress cytokine signaling and TNF production | Cytokine feedback inhibition |
| IRF proteins | Modulate TNF transcription in macrophages | Transcriptional regulation |
| NF-κB inhibitors | Prevent NF-κB-driven TNF transcription | Inflammatory signaling control |
| AU-rich element binding proteins | Control TNF mRNA stability | Post-transcriptional regulation |
| MicroRNA machinery | miRNAs target TNF mRNA for degradation | Fine-tuning of TNF production |
How Is negative regulation of tumor necrosis factor production Regulated?
Negative regulation of TNF production is controlled by multiple layers of feedback. Tristetraprolin (TTP) is a key RNA-binding protein that destabilizes TNF mRNA in response to p38 MAPK signaling. NLRP12 acts as a negative regulator in macrophages, likely through inhibition of NF-κB and MAPK pathways. N-glycosylation of proteins can negatively regulate TNF expression, suggesting a role for glycosylation pathways in this process. CD40 ligation in microglia can modulate TNF-alpha expression, indicating cell-type-specific regulation. Additionally, dietary essential fatty acid balance influences TNF production, linking metabolic status to GO:0032720. These regulatory mechanisms ensure that TNF production is transient and self-limiting [5,6].
negative regulation of tumor necrosis factor production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ZFP36 (TTP) | Inflammatory arthritis, cachexia | Zfp36 knockout mouse; LPS-stimulated macrophages |
| NLRP12 | Autoinflammatory disease, melioidosis | Nlrp12 knockout RAW264.7 macrophages |
| Lps(d)/Ran | Sepsis, endotoxin tolerance | Lps(d)/Ran transgenic mice |
| CD40 | Neuroinflammation | BV-2 microglial cells with CD40 ligation |
| N-glycosylation enzymes | Inflammatory macrophage activation | Mouse macrophages with glycosylation inhibitors |
Inflammatory and autoimmune diseases
Loss of negative regulation of TNF production leads to excessive TNF, which is a hallmark of rheumatoid arthritis, inflammatory bowel disease, and psoriasis. Tristetraprolin-deficient mice develop severe inflammatory arthritis and cachexia due to uncontrolled TNF production. NLRP12 mutations have been associated with autoinflammatory disorders, further linking negative regulation of TNF to disease. Enhancing TTP activity or mimicking its effects is a potential therapeutic strategy.
Sepsis and acute inflammation
During sepsis, an uncontrolled TNF burst can cause septic shock and multi-organ failure. Dominant negative Lps(d)/Ran down-regulates endotoxin-induced TNF-alpha production, suggesting genetic approaches to limit TNF in sepsis. NLRP12 attenuates TNF-alpha in Burkholderia pseudomallei infection, a model for severe bacterial sepsis. Thus, GO:0032720 is central to sepsis pathophysiology [3,8].
Cancer-related inflammation
Chronic TNF production promotes tumorigenesis by driving inflammation, angiogenesis, and survival signals. Negative regulators of TNF production may act as tumor suppressors by limiting the inflammatory microenvironment. Understanding GO:0032720 could inform cancer immunotherapies that aim to modulate TNF levels.
Metabolic and nutritional modulation
Dietary essential fatty acid balance regulates TNF production in mouse macrophages, linking nutrition to GO:0032720. This suggests that metabolic interventions could modulate TNF-related diseases. N-glycosylation also connects cellular metabolism to TNF regulation.
From negative regulation of tumor necrosis factor production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ZFP36 negatively regulate TNF production in macrophages? | Zfp36 knockout and knock-in mouse models |
| What is the role of NLRP12 in TNF attenuation during infection? | Nlrp12 knockout RAW264.7 macrophages |
| How does N-glycosylation affect TNF expression? | Mouse macrophages with glycosylation pathway knockout |
| Can CD40 signaling modulate TNF in microglia? | BV-2 microglial cells with CD40 overexpression or knockout |
| Does Lps(d)/Ran down-regulate endotoxin-induced TNF? | Lps(d)/Ran transgenic mice |
| How does dietary fatty acid balance regulate TNF? | Mouse macrophages cultured with varying fatty acids |
How to Study the negative regulation of tumor necrosis factor production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | TNF mRNA levels and transcriptome changes | Identifying negative regulators of TNF transcription |
| qPCR | TNF mRNA abundance | Validating transcriptional repression |
| ELISA | Secreted TNF protein | Quantifying negative regulation of TNF production |
| Western blot | Intracellular TNF protein | Assessing translational or post-translational control |
| mRNA stability assay | TNF mRNA half-life | Studying tristetraprolin-mediated decay |
| CRISPR knockout screen | Genes whose loss increases TNF production | Discovering novel negative regulators [6,8] |
| Flow cytometry | TNF-producing cells | Single-cell analysis of TNF regulation |
| Luciferase reporter assay | TNF promoter activity | Measuring transcriptional repression |
Transcriptional profiling (RNA-seq, qPCR)
RNA-seq and qPCR can quantify TNF mRNA levels in response to negative regulators [5,6]. These methods measure transcriptional repression and mRNA stability changes. They are widely used to study GO:0032720 in macrophages and monocytes.
Protein quantification (ELISA, Western blot)
ELISA and Western blot measure secreted and intracellular TNF protein levels, directly assessing negative regulation of production [3,4]. These are standard readouts for GO:0032720 [3,4].
mRNA stability assays
Actinomycin D chase assays measure TNF mRNA half-life to assess post-transcriptional regulation by proteins such as tristetraprolin. This method is key for studying mRNA destabilization mechanisms.
CRISPR screens and functional genomics
Pooled CRISPR knockout screens can identify novel negative regulators of TNF production by selecting for cells with increased TNF output [6,8]. These screens are powerful for discovering genes in GO:0032720 [6,8].
How CRISPR Can Be Used to Study GO:0032720 negative regulation of tumor necrosis factor production
Knockout
CRISPR knockout of candidate negative regulators such as ZFP36 or NLRP12 can confirm their role in suppressing TNF production [3,6]. Loss-of-function models show increased TNF levels upon stimulation, validating GO:0032720 annotations [3,6].
Point Mutation
Point mutations can be introduced into TNF AU-rich elements or into regulatory proteins to dissect specific residues required for negative regulation. For example, mutating TTP zinc finger domains can abolish its ability to destabilize TNF mRNA.
Knock-in
Knock-in of tagged versions of negative regulators (e.g., GFP-TTP) allows visualization and immunoprecipitation of the protein in macrophages. This helps map interactions with TNF mRNA and other factors.
Overexpression
Overexpression of negative regulators such as NLRP12 or TTP can suppress TNF production, providing gain-of-function evidence for GO:0032720 [3,6]. This approach is useful for testing therapeutic potential [3,6].
How EDITGENE Supports negative regulation of tumor necrosis factor production Research
Researchers studying negative regulation of tumor necrosis factor production-related genes often need to determine whether a candidate gene is causally involved in suppressing TNF. EDITGENE provides CRISPR-based cell model services to enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of tumor necrosis factor production research.
Frequently Asked Questions About negative regulation of tumor necrosis factor production
What is GO:0032720?
GO:0032720 is the Gene Ontology term for negative regulation of tumor necrosis factor production, describing any process that stops, prevents, or reduces TNF production [1,2,5].
What genes are involved in negative regulation of tumor necrosis factor production?
Key genes include ZFP36 (tristetraprolin), NLRP12, CD40, and Lps(d)/Ran, as shown in macrophage and microglial studies [2,3,6,8].
How is TNF production negatively regulated?
TNF production is negatively regulated at transcriptional, post-transcriptional (mRNA decay), translational, and secretory levels [5,6].
What is the role of tristetraprolin in TNF regulation?
Tristetraprolin binds AU-rich elements in TNF mRNA and promotes its degradation, providing feedback inhibition of TNF production.
How does NLRP12 regulate TNF?
NLRP12 attenuates TNF-alpha production in Burkholderia pseudomallei-infected macrophages, acting as a negative regulator.
Can N-glycosylation affect TNF production?
Yes, N-glycosylation negatively regulates TNF expression in mouse macrophages.
What diseases are linked to defective negative regulation of TNF?
Defective negative regulation of TNF is linked to inflammatory arthritis, sepsis, autoinflammatory diseases, and cancer-related inflammation [3,5,6,8].
How can CRISPR be used to study negative regulation of TNF?
CRISPR knockout, knock-in, point mutation, and overexpression models can test causal roles of candidate genes in suppressing TNF production [3,6,8].
What methods measure negative regulation of TNF production?
ELISA, Western blot, qPCR, RNA-seq, mRNA stability assays, and CRISPR screens are commonly used [3,4,5,6].
Does diet influence negative regulation of TNF production?
Dietary essential fatty acid balance can regulate TNF production in mouse macrophages.
Conclusion
GO:0032720, negative regulation of tumor necrosis factor production, is a critical biological process that restrains one of the most potent inflammatory cytokines. Research has identified multiple layers of control, including mRNA destabilization by tristetraprolin, inhibition by NLRP12, and post-translational modification by N-glycosylation [3,4,6]. Dysregulation of this process contributes to sepsis, autoimmune diseases, and cancer-related inflammation [3,5,8]. CRISPR-based models are powerful tools to dissect these mechanisms and identify new therapeutic targets [6,8]. EDITGENE provides comprehensive CRISPR services, including knockout, point mutation, knock-in, overexpression, and library screening, to accelerate research on negative regulation of TNF production. By combining precise genome editing with bioinformatics, we help researchers uncover causal genes and translate findings into clinical applications.
References
- 1. Wang M et al.. 2017. Regulation of myocardial stromal cell-derived factor 1α/CXCL12 by tumor necrosis factor signaling.. J Surg Res 207:155-163 PMID: 27979472
- 2. Jana M et al.. 2002. Regulation of tumor necrosis factor-alpha expression by CD40 ligation in BV-2 microglial cells.. J Neurochem 80(1):197-206 PMID: 11796758
- 3. Pudla M et al.. 2025. NLRP12 attenuates tumor necrosis factor-α production in Burkholderia pseudomallei-infected RAW264.7 macrophages.. Asian Pac J Allergy Immunol 43(3):727-731 PMID: 36278779
- 4. Murakami M et al.. 2024. N-glycosylation negatively regulates the expression of tumor necrosis factor (TNF) in mouse macrophage.. Biochem Biophys Res Commun 737:150897 PMID: 39488087
- 5. Kohn FR et al.. 1992. Regulation of tumor necrosis factor-alpha production and gene expression in monocytes.. Bone Marrow Transplant 9(5):369-76 PMID: 1617321
- 6. Carballo E et al.. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin.. Science 281(5379):1001-5 PMID: 9703499
- 7. Watanabe S et al.. 1993. Regulation by dietary essential fatty acid balance of tumor necrosis factor production in mouse macrophages.. J Leukoc Biol 53(2):151-6 PMID: 7680370
- 8. Yuan Q et al.. 2000. Dominant negative down-regulation of endotoxin-induced tumor necrosis factor alpha production by Lps(d)/Ran.. Proc Natl Acad Sci U S A 97(6):2852-7 PMID: 10706609
